Intravenous self-administration of gamma-hydroxybutyric acid in drug-naive mice

European Neuropsychopharmacology

Volumn 8, Issue 4, 1998, Pages 293-296

  Martellotta, M C ^a   Cossu, G ^a   Fattore, L ^a   Gessa, G L ^a   Fratta, W ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Gamma hydroxybutyric acid (GHB); Mice; NCS 382; Self administration

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; NCS 382; PUTATIVE NEUROTRANSMITTER; UNCLASSIFIED DRUG;

ALCOHOL ABUSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT;

ANIMALS; CONDITIONING, OPERANT; HYDROXYBUTYRATES; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, INBRED STRAINS; SELF ADMINISTRATION;

EID: 0032401241     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(97)00087-4     Document Type: Article

References (28)

1. Cash C.D. Gamma-hydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent. Neurosci. Biobehav. Rev. 18:1994;291-304.
2. Colombo, G., Agabio, R., Balaklievskaia N., Diaz, G., Lobina, C., Reali, R., Gessa, G.L., 1995a. Oral self-administration of γ-hydroxybutyric acid in the rat. Eur. J. Pharmacol. 285, 103-107.
3. Colombo, G., Agabio, R., Lobina, C., Reali, R., Fadda, F., Gessa, G.L., 1995b. Symmetrical generalization between the discriminative stimulus effects of gamma-hydroxybutyric acid and ethanol: occurrence within narrow dose ranges. Physiol. Behav. 57, 105-111.
4. Colombo, G., Agabio, R., Lobina, C., Reali, R., Fadda, F., Gessa, G.L., 1995c. Cross tolerance to ethanol and γ-hydroxybutyric acid. Eur. J. Pharmacol. 273, 235-238.
5. Diana M., Mereu G., Mura A., Fadda F., Passino N., Gessa G.L. Low doses of γ-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats. Brain Res. 566:1991;208-211.
6. Fadda F., Mosca E., Colombo G., Gessa G.L. Gamma-hydroxybutyric acid suppresses ethanol consumption in alcohol-preferring rats. Psychopharmacology. 96(Suppl.):1988;107.
7. Fadda F., Colombo G., Mosca E., Gessa G.L. Suppression by gamma-hydroxybutyric acid of ethanol withdrawal syndrome in rats. Alcohol Alcohol. 24:1989;447-451.
8. Feigenbaum J.J., Howard S.G. Gamma-hydroxybutyrate is not a GABA agonist. Prog. Neurobiol. 50:1996;1-7.
9. Food and Drug Administration, 1991. Warning about GHB. J. Am. Med. Assoc. 285, 1802.
10. Frederick, S.L., Galloway, G.P., Staggers, F., Stalcup, S.A., Smith, D., 1994. Gamma-hydroxybutyrate: a putative neurotransmitter that is abused and causes physical dependence. In: Harris, L.S. (Ed.), Problems of Drug Dependence. National Institute on Drug Abuse Research Monograph Series, 153. National Institute on Drug Abuse, Rockville, MD, p. 101.
11. Gallimberti L., Gentile N., Cibin M., Fadda F., Canton G., Ferri M., Ferrara S.D., Gessa G.L. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet. 8666:1989;787-789.
12. Gallimberti L., Ferri M., Ferrara S.D., Fadda F., Gessa G.L. Gamma-hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study. Alcohol. Clin. Exp. Res. 16:1992;673-676.
13. Gallimberti L., Cibin M., Pagnin P., Sabbion R., Pani P.P., Pirastu R., Ferrara S.D., Gessa G.L. Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome. Neuropsychopharmacology. 9:1993;77-81.
14. Gessa G.L., Vargiu L., Crabai F., Boero G.C., Caboni F., Camba R. Selective increase of brain dopamine induced by gamma-hydroxybutyrate. Life Sci. 5:1966;1921-1930.
15. Kuzmin A., Zvartau E., Gessa G.L., Martellotta M.C., Fratta W. The calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice. Pharmacol. Biochem. Behav. 41:1992;497-500.
16. 2+ channel modulators. Eur. J. Pharmacol. 295, 19-25.
17. Kuzmin, A.V., Semenova, S., Zvartau, E.E., Van Ree, J.M., 1996b. Enhancement of morphine self-administration in drug naive, inbred strains of mice by acute emotional stress. Eur. Neuropsychopharmacol. 6, 63-68.
18. Kuzmin A.V., Semenova S., Gerrits M.A.F.M., Zvartau E.E., Van Ree J.M. K-Opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice. Eur. J. Pharmacol. 321:1997;265-271.
19. Laborit G., Larcan A., Kind A. Le gamma-hydroxybutyrate en anesthesie neurochirurgicale. Neurochirurgie. 8:1962;104-107.
20. Maitre, M., Rumigny, J.F., Cash, C.D., Mandel, P., 1983a. Subcellular distribution of γ-hydroxybutyrate acid binding sites in rats brain. Principal localization in the synaptosomal fraction. Biochem. Biophys. Res. Commun. 110, 262-265.
21. Maitre, M., Cash, C.D., Weissmann-Nanopoulos, D., Mandel, P., 1983b. Depolarization-evoked release of γ-hydroxybutyrate from rat brain slices. J. Neurochem. 41, 287-290.
22. Martellotta M.C., Kuzmin A., Zvartau E., Cossu G., Gessa G.L., Fratta W. Isradipine inhibits nicotine intravenous self-administration in drug-naive mice. Pharmacol. Biochem. Behav. 52:1995;271-274.
23. Martellotta M.C., Fattore L., Cossu G., Fratta W. Rewarding properties of gamma-hydroxybutyric acid: an evaluation through place-preference paradigm. Psychopharmacology. 132:1997;1-5.
24. Morgenroth V.H., Walters J.R., Roth R.H. Dopaminergic neurons. Alteration in the kinetic properties of tyrosine hydroxylase after cessation of impulse flow. Biochem. Pharmacol. 25:1976;655-661.
25. Nelson T., Kaufman E., Kline J., Sokoloff L. The extraneuronal distribution of γ-hydroxybutyrate. J. Neurochem. 37:1981;1345-1348.
26. Roth R.H. Formation and regional distribution of γ-hydroxybutyric acid in mammalian brain. Biochem. Pharmacol. 19:1970;3013-3019.
27. Stell J.M., Ryan J.M. Gamma-hydroxybutyrate is a new recreational drug that may lead to loss of consciousness. Br. Med. J. 313:1996;424.
28. Vayer P., Mandel P., Maitre M. Gamma-hydroxybutyrate, a possible neurotransmitter. Life Sci. 41:1987;1547-1557.